Histopathology, ultrastructure, and clinical phenotypes in thin glomerular basement membrane disease variants

被引:21
作者
Liapis, H
Gökden, N
Hmiel, P
Miner, JH
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Med, Renal Div, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA
关键词
thin glomerular basement membrane disease; variants; Alport syndrome; collagen IV; electron microscopy;
D O I
10.1053/hupa.2002.125374
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Recent genetic studies indicate that Alport syndrome and thin glomerular basement membrane disease (TMD) may both be due to COLAA3, COL4A4, and COL4A5 mutations, but there is continuing uncertainty concerning the diagnosis and management of patients without classic family history and symptoms. We examined kidney pathology and collagen alpha 3 to alpha 5(IV) expression in a series of 16 patients who presented with overlapping signs between TMD and Alport nephritis. All patients presented with hematuria, and 11 also had proteinuria, of whom 5 had nephrotic range proteinuria. Only 9 had family history of hematuria. In 9 of 16 (60%) we found premature glomerulosclerosis in the renal biopsies. Three of 16 had predominantly wide, lamellated glomerullar basement membranes (GBM), and in these, a 3 to a 5(IV) was absent in glomeruli or skin, diagnostic of Alport nephritis. One patient (12) had a very wide GBM with intramembranous lucencies but no lamellation. Skin biopsy was collagen a 5(IV) positive. Nine of 16 patients had predominantly thin GBM by electron microscopy, and 3 had thin and slightly lamellated GBM. Collagen a 3 to a 5(IV) expression in the kidney or skin biopsy was present in all of the latter 12 patients. Three patients had end-stage renal disease, 7 patients had hypertension, and 1 patient had chronic renal failure. We found that of the 16 patients with presumed TMD, 3 had X-linked Alport nephritis, 2 appeared to have autosomal recessive Alport nephritis, and the remaining patients had either an Alport or a TMD variant. The latter had histologic and/or clinical evidence of progressive renal disease, including premature glomerulosclerosis, hypertension, sustained proteinuria, and either thin or slight GBM lamellation focally, and preserved a 3 to a 5(IV) expression. These patients have a TMD variant, but an Alport variant with a potentially transmissible severe defect different from benign hematuria cannot be excluded. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:836 / 845
页数:10
相关论文
共 27 条
[1]   COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome [J].
Buzza, M ;
Wang, YY ;
Dagher, H ;
Babon, JJ ;
Cotton, RG ;
Powell, H ;
Dowling, J ;
Savige, J .
KIDNEY INTERNATIONAL, 2001, 60 (02) :480-483
[2]   Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome [J].
Buzza, M ;
Wilson, D ;
Savige, J .
KIDNEY INTERNATIONAL, 2001, 59 (05) :1670-1676
[3]   A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome [J].
Dagher, H ;
Buzza, M ;
Colville, D ;
Jones, C ;
Powell, H ;
Fassett, R ;
Wilson, D ;
Agar, J ;
Savige, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) :1217-1228
[4]   INCIDENCE OF THIN MEMBRANE NEPHROPATHY - MORPHOMETRIC INVESTIGATION OF A POPULATION-SAMPLE [J].
DISCHE, FE ;
ANDERSON, VER ;
KEANE, SJ ;
TAUBE, D ;
BEWICK, M ;
PARSONS, V .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (06) :457-460
[5]   Sporadic case of X-chromosomal Alport syndrome in a consanguineous family [J].
Ermisch, B ;
Gross, O ;
Netzer, KO ;
Weber, M ;
Brandis, M ;
Zimmerhackl, LB .
PEDIATRIC NEPHROLOGY, 2000, 14 (8-9) :758-761
[6]  
Frascá GM, 2000, J NEPHROL, V13, P15
[7]   AUTOSOMAL RECESSIVE ALPORT SYNDROME - IMMUNOHISTOCHEMICAL STUDY OF TYPE-IV COLLAGEN CHAIN DISTRIBUTION [J].
GUBLER, MC ;
KNEBELMANN, B ;
BEZIAU, A ;
BROYER, M ;
PIRSON, Y ;
HADDOUM, F ;
KLEPPEL, MM ;
ANTIGNAC, C .
KIDNEY INTERNATIONAL, 1995, 47 (04) :1142-1147
[8]  
Heidet L, 2001, J AM SOC NEPHROL, V12, P97, DOI 10.1681/ASN.V12197
[9]  
Jais JP, 2000, J AM SOC NEPHROL, V11, P649, DOI 10.1681/ASN.V114649
[10]  
KAPLAN C, 1975, AM J PATHOL, V80, P227